Nuedexta
Payments companies reported to CMS as associated with Nuedexta. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Nuedexta, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Nuedexta
These are the largest totals companies reported as associated with Nuedexta. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Amita Patel | Dayton, OH | Psychiatry | $151,515.41 |
| Mary Allen | Memphis, TN | Psychiatric/Mental Health (Nurse Practitioner) | $116,009.97 |
| Matthew Baker | Naples, FL | Neurology (Psychiatry & Neurology) | $90,536.35 |
| Steven Bromley | Audubon, NJ | Neurology (Psychiatry & Neurology) | $80,183.86 |
| Adam Sky | Saint Louis, MO | Psychiatry | $66,864.74 |
| Jason Caplan | Phoenix, AZ | Psychiatry | $57,066.46 |
| Fay Bembry | Johnson City, TN | Psychiatric/Mental Health (Nurse Practitioner) | $45,360.03 |
| Mayer Hasbani | New Haven, CT | Clinical Neurophysiology | $43,612.83 |
| Steven Fogelman | Rome, NY | Psychiatry | $43,515.20 |
| Michelle Dees | Chicago, IL | Psychiatry | $41,998.70 |
Prescribed Nuedexta?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.